Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
557-04-0
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2026-03-24
Product name
Fluphenazine Hydrochloride Tablets USP 1 mg, 2.5 mg, 5 mg, 10 mg
1.2.1 Relevant identified uses
Management of manifestations of psychotic disorders
Manufacturer Name
Hetero Labs Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Section 2
SECTION 2: Hazards identification
Potential health effects
Inhalation: Not expected to be hazardous in final pharmaceutical form. Eye Contact: Not expected to be hazardous in final pharmaceutical form. Skin Contact: Not expected to be hazardous in final pharmaceutical form. Ingestion: Health injuries are not known or expected under normal use. Exposures above clinical dosage could result in adverse effects. Minor occupational exposures are not expected to be harmful. Other: None. Effects of Overexposure The potential for exposure is reduced in finished pharmaceutical form.